|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.84 USD | +0.31% |
|
-2.19% | -14.50% |
| May. 01 | HSBC Adjusts Price Target on Bristol-Myers Squibb to $45 From $50 | MT |
| May. 01 | Editas Medicine, Bristol-Myers Squibb Extend Alpha-Beta T Cell Collaboration | MT |
April 22 (Reuters) - Bristol Myers Squibb and Cellares said on Monday they have reached a $380 million deal to supply CAR-T cell therapies to more patients.
(Reporting by Christy Santhosh; Editing by Shinjini Ganguli)
| 1st Jan change | Capi. | |
|---|---|---|
| -14.50% | 88.58B | |
| +26.84% | 681B | |
| +21.85% | 556B | |
| -4.94% | 361B | |
| +17.20% | 325B | |
| +5.85% | 285B | |
| +13.68% | 235B | |
| +3.65% | 199B | |
| -11.12% | 189B | |
| -3.89% | 157B |
BRISTOL-MYERS SQUIBB COMPANY 
